Infection with murine norovirus 4 does not alter helicobacter-induced inflammatory bowel disease in Il10-/- mice

Comparative Medicine

Volumn 64, Issue 4, 2014, Pages 256-263

  Hsu, Charlie C ^a   Paik, Jisun ^a   Treuting, Piper M ^a   Seamons, Audrey ^a   Meeker, Stacey M ^a   Brabb, Thea L ^a   Maggio Price, Lillian ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

BMDM, bone marrow derived macrophages; IBD, inflammatory bowel disease; MLN, mesenteric lymph node; MNV, murine norovirus

Indexed keywords

INTERLEUKIN 10; IL10 PROTEIN, MOUSE; IL1B PROTEIN, MOUSE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN-6, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; DISEASE SEVERITY; EVALUATION STUDY; EXPERIMENTAL INFECTION; FEMALE; GENE EXPRESSION; HELICOBACTER BILIS; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MACROPHAGE; MIXED INFECTION; MOUSE; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; PHENOTYPE; PROTEIN EXPRESSION; TROPISM; AGE; ANIMAL; CALICIVIRUS INFECTION; CELL CULTURE; DEFICIENCY; DISEASE MODEL; GASTROENTERITIS; GENETICS; GENOTYPE; HELICOBACTER; HELICOBACTER INFECTION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOGENICITY; SEVERITY OF ILLNESS INDEX; TH1 CELL; VIROLOGY;

AGE FACTORS; ANIMALS; CALICIVIRIDAE INFECTIONS; CELLS, CULTURED; COINFECTION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GASTROENTERITIS; GENOTYPE; HELICOBACTER; HELICOBACTER INFECTIONS; HOST-PATHOGEN INTERACTIONS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGES; MICE, KNOCKOUT; NOROVIRUS; PHENOTYPE; SEVERITY OF ILLNESS INDEX; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907977196     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Ammann CG, Messer RJ, Varvel K, Debuysscher BL, Lacasse RA, Pinto AK, Hasenkrug KJ. 2009. Effects of acute and chronic murine norovirus infections on immune responses and recovery from Friend retrovirus infection. J Virol 83:13037-13041.
2. Barron EL, Sosnovtsev SV, Bok K, Prikhodko V, Sandoval-Jaime C, Rhodes CR, Hasenkrug K, Carmody AB, Ward JM, Perdue K, Green KY. 2011. Diversity of murine norovirus strains isolated from asymptomatic mice of different genetic backgrounds within a single US research institute. PLoS ONE 6:e21435.
3. + Th1-like responses. J Clin Invest 98:1010-1020.
4. Bouma G, Strober W. 2003. The immunological and genetic basis of infammatory bowel disease. Nat Rev Immunol 3:521-533.
5. Buchler G, Wos-Oxley ML, Smoczek A, Zschemisch NH, Neumann D, Pieper DH, Hedrich HJ, Bleich A. 2012. Strain-specifc colitis susceptibility in IL10-defcient mice depends on complex gut microbiota-host interactions. Infamm Bowel Dis 18:943-954.
6. Burich A, Hershberg R, Waggie K, Zeng W, Brabb T, Westrich G, Viney JL, Maggio-Price L. 2001. Helicobacter-induced infamma-tory bowel disease in IL10-and T-cell-defcient mice. Am J Physiol Gastrointest Liver Physiol 281:G764-G778.
7. Cadwell K, Patel KK, Maloney NS, Liu TC, Ng AC, Storer CE, Head RD, Xavier R, Stappenbeck TS, Virgin HW. 2010. Virus plus susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141:1135-1145.
8. Chachu KA, LoBue AD, Strong DW, Baric RS, Virgin HW. 2008. Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. PLoS Pathog 4:e1000236.
9. Chachu KA, Strong DW, LoBue AD, Wobus CE, Baric RS, Virgin HW 4th. 2008. Antibody is critical for the clearance of murine noro-virus infection. J Virol 82:6610-6617.
10. Chen X, Leach D, Hunter DA, Sanfelippo D, Buell EJ, Zemple SJ, Grayson MH. 2011. Characterization of intestinal dendritic cells in murine norovirus infection. Open Immunol J 4:22-30.
11. Chichlowski M, Sharp JM, Vanderford DA, Myles MH, Hale LP. 2008. Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon infammation and infammation-associ-ated neoplasia in IL10-defcient mice. Comp Med 58:534-541.
12. Danese S. 2011. IBD: of mice and men-shedding new light on IL13 activity in IBD. Nat Rev Gastroenterol Hepatol 8:128-129.
13. Doom CM, Turula HM, Hill AB. 2009. Investigation of the impact of the common animal facility contaminant murine norovirus on experimental murine cytomegalovirus infection. Virology 392:153-161.
14. Duell BL, Ta n CK, Carey AJ, Wu F, Cripps AW, Ulett GC. 2012. Recent insights into microbial triggers of interleukin 10 production in the host and the impact on infectious disease pathogenesis. FEMS Immunol Med Microbiol 64:295-313.
15. Dyson JK, Rutter MD. 2012. Colorectal cancer in infammatory bowel disease: what is the real magnitude of the risk? World J Gastroenterol 18:3839-3848.
16. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. 2005. Experimental models of infammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206:260-276.
17. Ericsson AC, Myles M, Davis W, Ma L, Lewis M, Maggio-Price L, Franklin C. 2010. Noninvasive detection of infammation-associated colon cancer in a mouse model. Neoplasia 12:1054-1065.
18. Farkas T, Fey B, Keller G, Martella V, Egyed L. 2012. Molecular detection of murine noroviruses in laboratory and wild mice. Vet Microbiol 160:463-467.
19. Green KY. 2007. Caliciviridae: the noroviruses, p 949-979. In: Fields BN, Knipe DM, Howley PM, editors. Fields' virology, 5th ed. Philadelphia (PA): Lippincott, Williams, and Wilkins.
20. Hale LP, Greer PK. 2012. A novel murine model of infammatory bowel disease and infammation-associated colon cancer with ul-cerative colitis-like features. PLoS ONE 7:e41797.
21. -/- mice. Helicobacter 12:598-604.
22. Hensley SE, Pinto AK, Hickman HD, Kastenmayer RJ, Bennink JR, Virgin HW, Yewdell JW. 2009. Murine norovirus infection has no signifcant effect on adaptive immunity to vaccinia virus or infuenza A virus. J Virol 83:7357-7360.
23. Higgins PD, Johnson LA, Sauder K, Moons D, Blanco L, Taube S, Wobus CE. 2011. Transient or persistent norovirus infection does not alter the pathology of Salmonella typhimurium-induced intestinal infammation and fbrosis in mice. Comp Immunol Microbiol Infect Dis 34:247-257.
24. Hsu CC, Riley LK, Wills HM, Livingston RS. 2006. Persistent infection and serologic crossreactivity of 3 novel murine noroviruses. Comp Med 56:247-251.
25. Hsu CC, Wobus CE, Steffen EK, Riley LK, Livingston RS. 2005. Development of a microsphere-based serologic multiplexed fuorescent immunoassay and a reverse transcriptase PCR assay to detect murine norovirus 1 infection in mice. Clin Diagn Lab Immunol 12:1145-1151.
26. Kahan SM, Liu G, Reinhard MK, Hsu CC, Livingston RS, Karst SM. 2011. Comparative murine norovirus studies reveal a lack of correlation between intestinal virus titers and enteric pathology. Virology 421:202-210.
27. Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW. 2003. STAT1-dependent innate immunity to a Norwalk-like virus. Science 299:1575-1578.
28. Kim YG, Park JH, Reimer T, Baker DP, Kawai T, Kumar H, Akira S, Wobus C, Nunez G. 2011. Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections. Cell Host Microbe 9:496-507.
29. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. 1993. Interleukin10-defcient mice develop chronic enterocolitis. Cell 75:263-274.
30. Lencioni KC, Drivdahl R, Seamons A, Treuting PM, Brabb T, Maggio-Price L. 2011. Lack of effect of murine norovirus infection on a mouse model of bacteria-induced colon cancer. Comp Med 61:219-226.
31. Lencioni KC, Seamons A, Treuting PM, Maggio-Price L, Brabb T. 2008. Murine norovirus: an intercurrent variable in a mouse model of bacteria-induced infammatory bowel disease. Comp Med 58:522-533.
32. Mahida YR. 2000. The key role of macrophages in the immunopatho-genesis of infammatory bowel disease. Infamm Bowel Dis 6:21-33.
33. Mahler M, Leiter EH. 2002. Genetic and environmental context determines the course of colitis developing in IL10-defcient mice. Infamm Bowel Dis 8:347-355.
34. McCartney SA, Thackray LB, Gitlin L, Gilfllan S, Virgin HW, Colonna M. 2008. MDA5 recognition of a murine norovirus. PLoS Pathog 4:e1000108.
35. Muller B, Klemm U, Mas Marques A, Schreier E. 2007. Genetic diversity and recombination of murine noroviruses in immunocom-promised mice. Arch Virol 152:1709-1719.
36. Mumphrey SM, Changotra H, Moore TN, Heimann-Nichols ER, Wobus CE, Reilly MJ, Moghadamfalahi M, Shukla D, Karst SM. 2007. Murine norovirus 1 infection is associated with histopatho-logical changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J Virol 81:3251-3263.
37. Nell S, Suerbaum S, Josenhans C. 2010. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 8:564-577.
38. Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, Price VH, Grisham MB. 2009. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 296:G135-G146.
39. Paik J, Fierce Y, Drivdahl R, Treuting PM, Seamons A, Brabb T, Maggio-Price L. 2010. Effects of murine norovirus infection on a mouse model of diet-induced obesity and insulin resistance. Comp Med 60:189-195.
40. -/- mice. Comp Med 61:330-338.
41. Paul G, Khare V, Gasche C. 2012. Infamed gut mucosa: downstream of interleukin10. Eur J Clin Invest 42:95-109.
42. Perdue KA, Green KY, Copeland M, Barron E, Mandel M, Faucette LJ, Williams EM, Sosnovtsev SV, Elkins WR, Ward JM. 2007. Naturally occurring murine norovirus infection in a large research institution. J Am Assoc Lab Anim Sci 46:39-45.
43. Pritchett-Corning KR, Cosentino J, Clifford CB. 2009. Contemporary prevalence of infectious agents in laboratory mice and rats. Lab Anim 43:165-173.
44. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, Shugart YY, Griffths AM, Targan SR, Ippoliti AF, Bernard EJ, Mei L, Nicolae DL, Regueiro M, Schumm LP, Steinhart AH, Rotter JI, Duerr RH, Cho JH, Daly MJ, Brant SR. 2007. Genome-wide association study identifes new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39:596-604.
45. Rosenstiel P, Sina C, Franke A, Schreiber S. 2009. Towards a molecular risk map-recent advances on the etiology of infammatory bowel disease. Semin Immunol 21:334-345.
46. Rubin DC, Shaker A, Levin MS. 2012. Chronic intestinal infamma-tion: infammatory bowel disease and colitis-associated colon cancer. Front Immunol 3:107.
47. Rutella S, Locatelli F. 2011. Intestinal dendritic cells in the patho-genesis of inflammatory bowel disease. World J Gastroenterol 17:3761-3775.
48. Thackray LB, Duan E, Lazear HM, Kambal A, Schreiber RD, Diamond MS, Virgin HW. 2012. Critical role for interferon regulatory factor 3 (IRF3) and IRF7 in type I interferon-mediated control of murine norovirus replication. J Virol 86:13515-13523.
49. Torrence AE, Brabb T, Viney JL, Bielefeldt-Ohmann H, Treuting P, Seamons A, Drivdahl R, Zeng W, Maggio-Price L. 2008. Serum biomarkers in a mouse model of bacterial-induced infammatory bowel disease. Infamm Bowel Dis 14:480-490.
50. Watanabe N, Ikuta K, Okazaki K, Nakase H, Tabata Y, Matsuura M, Tamaki H, Kawanami C, Honjo T, Chiba T. 2003. Elimination of local macrophages in intestine prevents chronic colitis in interleukin10-defcient mice. Dig Dis Sci 48:408-414.
51. -/- mice results from IL13Rα2-mediated attenuation of IL13 activity. Gastroenterol-ogy 140:254-264.
52. Wirtz S, Neurath MF. 2007. Mouse models of infammatory bowel disease. Adv Drug Deliv Rev 59:1073-1083.
53. Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev SV, Belliot G, Krug A, Mackenzie JM, Green KY, Virgin HW. 2004. Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol 2:e432.
54. Wynn TA. 2003. IL13 effector functions. Annu Rev Immunol 21:425-456.
55. Xavier RJ, Podolsky DK. 2007. Unravelling the pathogenesis of infammatory bowel disease. Nature 448:427-434.
56. Yeom SC, Yu SA, Choi EY, Lee BC, Lee WJ. 2009. Prevalence of Helicobacter hepaticus, murine norovirus, and Pneumocystis carinii and eradication effcacy of cross-fostering in genetically engineered mice. Exp Anim 58:497-504.
57. Zhang L, Danon SJ, Grehan M, Chan V, Lee A, Mitchell H. 2005. Natural colonization with Helicobacter species and the development of infammatory bowel disease in interleukin-10-defcient mice. Helicobacter 10:223-230.